David Mantus
2018
In 2018, David Mantus earned a total compensation of $1.1M as Former Chief Development Officer at X4 Pharmaceuticals, a 149% increase compared to previous year.
Compensation breakdown
| Option Awards | $595,885 |
|---|---|
| Salary | $358,750 |
| Other | $120,250 |
| Total | $1,074,885 |
Mantus received $595.9K in option awards, accounting for 55% of the total pay in 2018.
Mantus also received $358.8K in salary and $120.3K in other compensation.
Rankings
In 2018, David Mantus' compensation ranked 8,865th out of 14,244 executives tracked by ExecPay. In other words, Mantus earned more than 37.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,865 out of 14,244 | 38th |
Division Manufacturing | 3,528 out of 5,765 | 39th |
Major group Chemicals And Allied Products | 1,335 out of 2,128 | 37th |
Industry group Drugs | 1,118 out of 1,817 | 39th |
Industry Biological Products, Except Diagnostic Substances | 212 out of 339 | 38th |
Source: SEC filing on May 22, 2019.
Mantus' colleagues
We found five more compensation records of executives who worked with David Mantus at X4 Pharmaceuticals in 2018.
2018
René BCPS
X4 Pharmaceuticals
Chief Executive Officer
2018
Michael Gray
X4 Pharmaceuticals
Chief Executive Officer
2018
Christopher Stevens
X4 Pharmaceuticals
Chief Medical Officer
2018
Paula Ragan
X4 Pharmaceuticals
Chief Executive Officer
2018
Adam Mostafa
X4 Pharmaceuticals